GA Depot (Long-acting IM Injection of Glatiramer Acetate) Impact on EDSS Stability in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) (P11-1.014)
To analyze the effect of GA Depot on disability accumulation using EDSS data from GA Depot clinical studies in RMS and PPMS patients
Authors
- Ehud Marom
- Uri Danon
- Nadav Bleich Kimelman
- Joseph R. Berger (ORCID: https://orcid.org/0000-0002-0260-2430)
- Shai Rubnov
- Arnon Karni (ORCID: https://orcid.org/0000-0002-5625-7900)
- Laura Popper
- Amit Bar‐Or (ORCID: https://orcid.org/0000-0001-7179-0335)
- Robert Zivadinov (ORCID: https://orcid.org/0000-0002-7799-1485)
- Hadar Kolb (ORCID: https://orcid.org/0000-0002-4178-5858)
- Aaron Miller (ORCID: https://orcid.org/0000-0001-8324-7356)
- Alexey Boykо (ORCID: https://orcid.org/0000-0003-4731-3250)
- Ornit Almog
Institutions
- Mount Sinai Hospital (US)
- California University of Pennsylvania (US)
- Mapi Research Trust (FR)
- Buffalo Psychiatric Center (US)
- Mapi Pharma (Israel) (IL)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211427
- Primary Topic
- Biopolymer Synthesis and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00